Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, United States of America.
California Proton Cancer Therapy Center, San Diego, CA 92121, United States of America.
Phys Med Biol. 2021 Feb 16;66(5):054001. doi: 10.1088/1361-6560/abdd89.
Proton radiotherapy treatment planning systems use a constant relative biological effectiveness (RBE) = 1.1 to convert proton absorbed dose into biologically equivalent high-energy photon dose. This method ignores linear energy transfer (LET) distributions, and RBE is known to change as a function of LET. Variable RBE approaches have been proposed for proton planning optimization. Experimental validation of models underlying these approaches is a pre-requisite for their clinical implementation. This validation has to probe every level in the evolution of radiation-induced biological damage leading to cell death, starting from DNA double-strand breaks (DSB). Using a novel FIESTA-DNA probe, we measured the probability of double-strand break (P ) along a 160 MeV proton Bragg curve at two dose levels (30 and 60 Gy (RBE)) and compared it to measurements in a 6 MV photon beam. A machined setup that held an Advanced Markus parallel plate chamber for proton dose verification alongside the probes was fabricated. Each sample set consisted of five 10 μl probes suspended inside plastic microcapillary tubes. These were irradiated with protons to 30 Gy (RBE) at depths of 5-17.5 cm and 60 Gy (RBE) at depths of 10-17.2 cm with 1 mm resolution around Bragg peak. Sample sets were also irradiated using 6MV photons to 20, 40, 60, and 80 Gy. For the 30 Gy (RBE) measurements, increases in P /Gy were observed at 17.0 cm followed by decreases at larger depth. For the 60 Gy (RBE) measurements, no increase in P /Gy was observed, but there was a decrease after 17.0 cm. Dose-response for P between 30 and 60 Gy (RBE) showed less than doubling of P when dose was doubled. Proton RBE effect from DSB, RBE, was <1 except at the Bragg peak. The experiment showed that the novel probe can be used to perform DNA DSB measurements in a proton beam. To establish relevance to clinical environment, further investigation of the probe's chemical scavenging needs to be performed.
质子放射治疗计划系统使用恒定的相对生物效应(RBE)= 1.1 将质子吸收剂量转换为生物等效的高能光子剂量。这种方法忽略了线性能量传递(LET)分布,并且 RBE 已知会随 LET 而变化。已经提出了可变 RBE 方法来优化质子计划。这些方法的基础模型的实验验证是将其临床实施的前提。这种验证必须探测导致细胞死亡的辐射诱导生物损伤的演变的每一个水平,从 DNA 双链断裂(DSB)开始。使用新型 FIESTA-DNA 探针,我们测量了在两个剂量水平(30 和 60 Gy(RBE))沿 160 MeV 质子布拉格曲线上的双链断裂(P)的概率,并将其与 6 MV 光子束中的测量结果进行了比较。制造了一个加工装置,该装置在探针旁边放置了一个用于质子剂量验证的高级马库斯平行板室。每个样品组由五个 10 μl 的探针组成,这些探针悬浮在塑料微毛细管管内。这些探针在布拉格峰周围以 1mm 的分辨率在 5-17.5cm 处用 30 Gy(RBE)照射,在 10-17.2cm 处用 60 Gy(RBE)照射。样品组还使用 6MV 光子照射 20、40、60 和 80Gy。对于 30 Gy(RBE)测量,在 17.0cm 处观察到 P /Gy 的增加,然后在更大的深度处减少。对于 60 Gy(RBE)测量,没有观察到 P /Gy 的增加,但在 17.0cm 后减少。在 30 和 60 Gy(RBE)之间,当剂量加倍时,P 的倍数小于两倍。除了在布拉格峰处之外,质子 RBE 效应从 DSB(RBE)<1。该实验表明,新型探针可用于在质子束中进行 DNA DSB 测量。为了与临床环境建立相关性,需要进一步研究探针的化学清除作用。